Conference Coverage: EHA 2022 – Focus on Leukemia and MDS (Global)
Expert perspectives on the latest therapeutic developments, treatment approaches, and implications for clinical decision-making regarding leukemia
Faculty Chair
Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX, USA
Faculty Members
Ibrahim T. Aldoss, MD
City of Hope National Medical Center, Duarte, CA, USA
Tapan M. Kadia, MD
MD Anderson Cancer Center, Houston, TX, USA
David Sallman, MD
Moffitt Cancer Center, Tampa, FL, USA
Rami Komrokji, MD
Moffitt Cancer Center, Tampa, FL, USA
Jae Park, MD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Josep-Maria Ribera, MD, PhD
Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
Nicola Gökbuget, MD
Goethe University Hospital, Frankfurt, Germany
Stéphane De Botton, MD, PhD
Hôpital Saint-Louis, Université de Paris, Paris, France
Pierre Fenaux, MD, PhD
Hôpital Saint-Louis, Université de Paris, Paris, France
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- New Developments in MDS
- Advances in AML: Newly Diagnosed
- Advances in AML: Relapsed/Refractory
